Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sarcoma Oncology Center, Santa Monica, California, United States
Contact: Study coordinator (Victoria Chua) · vchua@sarcomaoncology.com · 310-552-9999
Contact: Study coordinator (Sant P Chawla, MD) · santchawla@sarcomaoncology.com · 310-552-9999

Study leads

Sant P Chawla, MD
Principal Investigator
Sarcoma Oncology Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma

Metastatic Soft-tissue Sarcoma

Abroad (travel likely)RecruitingPHASE1

St Louis, United States

tTF-NGR Randomized Study - STS

Soft Tissue Sarcoma

Abroad (travel likely)RecruitingPHASE3

Bad Saarow, Germany · Berlin, Germany

Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma

Retroperitoneal Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chicago, United States

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Colorectal Carcinoma · Endometrial Carcinoma · Melanoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United States · Los Angeles, United States